Abstract
Alzheimer disease(AD) affects profoundly the quality of human life. Quantifying the severity degree of Alzheimer dementia for an individual person is critical for the early diagnose and prescription for delaying the further dementia progression. However, the quantitative diagnose for human subjects of the mild cognitively impairment(MCI) or AD with the different degree of dementia severity is a difficult task due to both the very broad distribution of dementia severities and the lack of good quantitative determinant to assess it. Here, based on cortical thickness profiles of human brains measured by magnetic resonance experiment, a new algebraic approach is presented for the personalized quantification of the severity degree of AD, ranging from 0 for the basin of cognitively normal state to 1 for AD state. Now one can unfold the broad distribution of dementia severities and corresponding cortex regions of human brains with MCI or AD by the different severity degree.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Research Foundation, Korea [grant number NRF 2017R1E1A1A03070854].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Alzheimers Disease Neuroimaging Initiative
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
Data Availability
Data used in preparation of this article were obtained from the Alzheimers Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
